Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sanjivani paranteral Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Sanjivani paranteral Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    18 Feb 2026, 6:50PM Easnings call Transcript date 16th February, 2026
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    17 Feb 2026, 12:36PM Outcome of the Investors & Analysts for Q3 FY26 Results
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    16 Feb 2026, 11:24AM Revised Press Relase for the Quarter ended 31st December, 2025
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    13 Feb 2026, 8:54PM As per attached Documnets
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Investor Presentation

    13 Feb 2026, 8:50PM As Per Attached Documnet.
  • Sanjivani parant Q3 net profit up 37.89% at Rs 2.62 cr

    13 Feb 2026, 8:10PM The company reported standalone net profit of Rs 2.62 crore for the quarter ended December 31, 2025 as compared to Rs 1.90 crore in the same period la
  • Sanjivani parant - Unaudited Financial Results Along With Limited Review Report Third Quarter And Nine Months Ended 31St Dece

    13 Feb 2026, 5:21PM Unaudited Financial Results along with Limited Review Report as submitted by the Statutory Auditor of the Company for the Third Quater and Nine Months
  • Sanjivani parant - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 13Th February, 2026.

    13 Feb 2026, 5:11PM Unaudited Financial Results along with Limited Review Report as submitted by the\r\nstatutory auditor of the Company for the Third Quarter and Nine Mo
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Feb 2026, 6:53PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Compan
  • Sanjivani parant - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Feb 2026, 4:58PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Compan
  • Sanjivani parant - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday, 13Th February, 20

    4 Feb 2026, 4:42PM Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider
  • Sanjivani parant has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    12 Jan 2026, 4:50PM As of December 2025, 31.20% is owned by Indian Promoters and 68.80% by Public. <p align=justify> Top two Promoters holding highest number of shares of
  • Sanjivani parant - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jan 2026, 6:07PM Certificate under regulation 74(5) for the Quarter ended 31st December, 2025

Key fundamentals

Evaluate the intrinsic value of Sanjivani paranteral Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 43.6252 28.8678 -0.5776 -4.8343 -2.9907
Liabilities 43.6252 28.8678 -0.5776 -4.8343 -2.9907
Equity 11.8816 11.6843 9.9983 9.9983 8.4983
Gross Profit 10.36 8.241 5.6372 5.7258 2.1402
Net Profit 8.1018 6.1651 4.5115 4.8464 1.4193
Cash From Operating Activities -0.2385 -10.7033 4.6843 8.5198 0.5829
NPM(%) 11.55 11.33 12.71 15.83 5.65
Revenue 70.0986 54.4105 35.4915 30.6126 25.0998
Expenses 59.7385 46.1695 29.8543 24.8867 22.9596
ROE(%) 17.01 12.95 9.47 10.18 2.98

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sanjivani paranteral Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 675.00 -0.72 40.03 93.28 301.39 0.74
Lotus Eye Hospital and Institute Ltd 106.95 1.57 345.74 339.92 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 16.28 -3.78 0.00 705.78 -39.50 0.00
Astec Lifesciences Ltd 581.00 -6.96 0.00 320.55 -604.75 0.00

Company Info

SANJIVANI PARANTERAL LTD. was incorporated as a Public Limited Company with Registrar of Companies, Maharashtra. The Company obtained Certificate of incorporation on 05/10/1004 and Certificate for Commencement of Business on 24/11/1994. The Company is jointly promoted by a team of professionals in various fields of Pharmaceutical industry. Mr. Anami H. Khemka aged 52 years, is associated with Pharmaceutical industry for last more than 10 years with specialisation in Marketing and Exports. He has wide experience of business in general and Marketing in particular. He has good commercial relations with first line Pharmaceutical companies. His entrepreneurship can be guaged from the fact that he had taken over a sick unit M/s. Sanjeevanee Pharmaceuticals Pvt. Ltd. and in a short period of three years converted the sick unit into a totally healthy profitable unit. 2004 -Company has Bagged order for the supply of 3 million Units of Cephalosporin to CIS Market. 2005 -Company has received the order of approx. Rs 316.80 million from Kerela Government. 2006 -Company has added milestone by securing the bid of CMS Tender of West Bengal Government for bulk supply to all the Hospitals of West Bengal Government -Company has bagged the prestigious order of Mumbai Municipal Corporation 2007 -Sanjivani Paranteral Ltd has has entered in the rate contracts with Defence Ministry of India for three years. Initial order received for Rs 5.00 Cr. which has to be executed in Feb'07 itself. -Company has launched new product of the Company namely SANCIDAL 2008 -Company has acquired a new pharmaceutical manufacturing plant in Uttarakhand.2025-The Company Started Commercial production at IV Fluid Infusion Plant. 

SANJIVANI PARANTERAL LTD. was incorporated as a Public Limited Company with Registrar of Companies, Maharashtra. The Company obtained Certificate of incorporation on 05/10/1004 and Certificate for Commencement of Business on 24/11/1994. The Company is jointly promoted by a team of professionals in various fields of Pharmaceutical industry. Mr. Anami H. Khemka aged 52 years, is associated with Pharmaceutical industry for last more than 10 years with specialisation in Marketing and Exports. He has wide experience of business in general and Marketing in particular. He has good commercial relations with first line Pharmaceutical companies. His entrepreneurship can be guaged from the fact that he had taken over a sick unit M/s. Sanjeevanee Pharmaceuticals Pvt. Ltd. and in a short period of three years converted the sick unit into a totally healthy profitable unit. 2004 -Company has Bagged order for the supply of 3 million Units of Cephalosporin to CIS Market. 2005 -Company has received the order of approx. Rs 316.80 million from Kerela Government. 2006 -Company has added milestone by securing the bid of CMS Tender of West Bengal Government for bulk supply to all the Hospitals of West Bengal Government -Company has bagged the prestigious order of Mumbai Municipal Corporation 2007 -Sanjivani Paranteral Ltd has has entered in the rate contracts with Defence Ministry of India for three years. Initial order received for Rs 5.00 Cr. which has to be executed in Feb'07 itself. -Company has launched new product of the Company namely SANCIDAL 2008 -Company has acquired a new pharmaceutical manufacturing plant in Uttarakhand.2025-The Company Started Commercial production at IV Fluid Infusion Plant. 

Read More

Parent Organisation

Sanjivani paranteral Ltd.

Founded

05/10/1994

Managing Director

Mr.Ashwani Khemka

NSE Symbol

FAQ

The current price of Sanjivani paranteral Ltd is

The 52-week high for Sanjivani paranteral Ltd is

The market capitalization of Sanjivani paranteral Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sanjivani paranteral Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sanjivani paranteral Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sanjivani paranteral Ltd shares.

The CEO of Sanjivani paranteral Ltd is Mr.Ashwani Khemka, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT